Cargando…

Experimental Data and PBPK Modeling Quantify Antibody Interference in PEGylated Drug Carrier Delivery

Physiologically-based pharmacokinetic (PBPK) modeling is a popular drug development tool that integrates physiology, drug physicochemical properties, preclinical data, and clinical information to predict drug systemic disposition. Since PBPK models seek to capture complex physiology, parameter uncer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talkington, Anne M., Wessler, Timothy, Lai, Samuel K., Cao, Yanguang, Forest, M. Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576315/ https://www.ncbi.nlm.nih.gov/pubmed/34751832 http://dx.doi.org/10.1007/s11538-021-00950-z

Ejemplares similares

Antibody protection from SARS-CoV-2 respiratory tract exposure and infection
por: Chen, Alex, et al.
Publicado: (2023)

A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2022)

Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model
por: Kuepfer, L, et al.
Publicado: (2016)

A blueprint for robust crosslinking of mobile species in biogels with weakly adhesive molecular anchors
por: Newby, Jay, et al.
Publicado: (2017)

PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer’s disease
por: Bloomingdale, Peter, et al.
Publicado: (2022)

Incorporating Target Shedding Into a Minimal PBPK–TMDD Model for Monoclonal Antibodies
por: Li, L, et al.
Publicado: (2014)

PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
por: Castillo, Paula M, et al.
Publicado: (2014)

A Physiologically Based Pharmacokinetic Framework for Quantifying Antibody Distribution Gradients from Tumors to Tumor-Draining Lymph Nodes
por: Salgado, Eric, et al.
Publicado: (2022)

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK
por: Wagner, C, et al.
Publicado: (2015)

PBPK Model for Atrazine and Its Chlorotriazine Metabolites in Rat and Human
por: Campbell, Jerry L., et al.
Publicado: (2016)

Modeling identifies variability in SARS-CoV-2 uptake and eclipse phase by infected cells as principal drivers of extreme variability in nasal viral load in the 48 h post infection
por: Pearson, Jason, et al.
Publicado: (2023)

Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution
por: Zazo, Hinojal, et al.
Publicado: (2022)

PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells
por: Esfahani, Maedeh Koohi Moftakhari, et al.
Publicado: (2021)

Minimal brain PBPK model to support the preclinical and clinical development of antibody therapeutics for CNS diseases
por: Bloomingdale, Peter, et al.
Publicado: (2021)

PBPK modeling and simulation in drug research and development
por: Zhuang, Xiaomei, et al.
Publicado: (2016)

Modeling insights into SARS-CoV-2 respiratory tract infections prior to immune protection
por: Chen, Alexander, et al.
Publicado: (2022)

Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers
por: Muralidharan, Priya, et al.
Publicado: (2014)

Quantifying Charge Carrier Localization in PBTTT Using Thermoelectric and Spectroscopic Techniques
por: Gregory, Shawn A., et al.
Publicado: (2023)

Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review
por: Shiraishi, Kouichi, et al.
Publicado: (2019)

A Workflow for Global Sensitivity Analysis of PBPK Models
por: McNally, Kevin, et al.
Publicado: (2011)

PBPK Modeling on Organs-on-Chips: An Overview of Recent Advancements
por: Yang, Yi, et al.
Publicado: (2022)

Permeability of Gemcitabine and PBPK Modeling to Assess Oral Administration
por: Ferreira, Abigail, et al.
Publicado: (2021)

Physiologically Based Pharmacokinetic (PBPK) Modeling of Metabolic Pathways of Bromochloromethane in Rats
por: Cuello, W. S., et al.
Publicado: (2012)

Magnetic delivery of antitumor carboplatin by using PEGylated-Niosomes
por: Davarpanah, Fereshteh, et al.
Publicado: (2018)

Targeted Delivery of Pennyroyal via Methotrexate Functionalized PEGylated Nanostructured Lipid Carriers into Breast Cancer Cells; A Multiple Pathways Apoptosis Activator
por: Mahoutforoush, Amin, et al.
Publicado: (2023)

PBPK perspective on alternative CYP3A4 inducers for rifampin
por: Chen, Kuan‐Fu, et al.
Publicado: (2022)

Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier
por: Hayashida, Kayoko, et al.
Publicado: (2014)

Evaluation of the PEG Density in the PEGylated Chitosan Nanoparticles as a Drug Carrier for Curcumin and Mitoxantrone
por: Chen, Yao, et al.
Publicado: (2018)

Antibodies against PEGylated enzymes: Treat them with respect!
por: Rutsch, Frank
Publicado: (2018)

Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
por: Jamei, Masoud
Publicado: (2020)

Current PBPK Models: Are They Predicting Tissue Drug Concentration Correctly?
por: Ibarra, Manuel, et al.
Publicado: (2020)

PBPK model reporting template for chemical risk assessment applications
por: Tan, Yu-Mei, et al.
Publicado: (2020)

PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver Disease
por: Montanha, Maiara Camotti, et al.
Publicado: (2022)

PKQuest: PBPK modeling of highly lipid soluble and extracellular solutes
por: Levitt, David G.
Publicado: (2018)

Complex Mixtures: Array PBPK Modeling of Jet Fuel Components
por: Sterner, Teresa R., et al.
Publicado: (2023)

PEGylation of nanoparticles improves their cytoplasmic transport
por: Suh, Junghae, et al.
Publicado: (2007)

Effect of pegylated phosphatidylserine-containing liposomes in experimental chronic arthritis
por: Urbano, Paulo CM, et al.
Publicado: (2015)

Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria
por: Bell, Sean M., et al.
Publicado: (2017)

Antibody-Mediated Immobilization of Virions in Mucus
por: Jensen, Melanie A., et al.
Publicado: (2019)

Stereocomplex-Reinforced PEGylated Polylactide Micelle for Optimized Drug Delivery
por: Feng, Chunsheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jg6nnagio1683thodkbpfpkq0s